Division of Clinical Pharmacology

November 13, 2014

Speaker explores promise of ‘bioelectronic medicine’

Can an implanted electrical device like a cardiac pacemaker effectively treat inflammatory diseases like rheumatoid arthritis, including cases that have not responded to drug therapy?

By Bill Snyder
November 7, 2014

Overactive stress response in obesity

An overactive stress response contributes to the development of insulin resistance in obese individuals, and blocking it may be therapeutically beneficial.

By VUMC News and Communications
October 24, 2014

Immune cells’ role in hypertension

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease.

By Leigh MacMillan
Cholesterol
August 21, 2014

Major grant spurs deeper look into ‘good cholesterol’

In some cases, HDL, the “good cholesterol,” may not function properly and may actually accelerate atherosclerosis.

By Bill Snyder
July 10, 2014

AHA grant creates coalition to prevent heart disease, stroke

Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world.

By Kathy Whitney
June 12, 2014

Roden named to NIH’s genomics advisory council

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH).

By Bill Snyder
May 12, 2014

Normalizing calcium flux to treat atrial fibrillation

A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation.
By Leigh MacMillan
April 16, 2014

Kudos: Read about faculty, staff and students’ awards and achievements

Read about faculty, staff and students' awards and achievements.
By VUMC News and Communications
February 10, 2014

Keeping the beat after heart surgery

Variation in the gene for the beta-1 adrenergic receptor increases the risk that a patient will have an abnormal heart rhythm after cardiac surgery.
By Leigh MacMillan
November 7, 2013

Neurotransmitter’s role in bone balance

Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling.
By Leigh MacMillan
August 15, 2013

Transplant drug added to PREDICT program

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.
By Bill Snyder
July 26, 2013

Reducing fatal rhythms after heart attack

Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.
By Courtney M. Campbell
June 13, 2013

Clinical Pharmacology celebrates 50th anniversary

Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.
By Bill Snyder
1 … 7 8 9 10 11